Search Results - "Conti, Giario"

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study by Bul, Meelan, Zhu, Xiaoye, Valdagni, Riccardo, Pickles, Tom, Kakehi, Yoshiyuki, Rannikko, Antti, Bjartell, Anders, van der Schoot, Deric K, Cornel, Erik B, Conti, Giario N, Boevé, Egbert R, Staerman, Frédéric, Vis-Maters, Jenneke J, Vergunst, Henk, Jaspars, Joris J, Strölin, Petra, van Muilekom, Erik, Schröder, Fritz H, Bangma, Chris H, Roobol, Monique J

“…Abstract Background Overdiagnosis and subsequent overtreatment are important side effects of screening for, and early detection of, prostate cancer (PCa)…”
Get full text

Salvage high‐intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi‐institutional analysis of 418 patients by Crouzet, Sebastien, Blana, Andreas, Murat, Francois J., Pasticier, Gilles, Brown, Stephen C. W., Conti, Giario N., Ganzer, Roman, Chapet, Olivier, Gelet, Albert, Chaussy, Christian G., Robertson, Cary N., Thuroff, Stefan, Ward, John F.

“…Objective To report the oncological outcome of salvage high‐intensity focused ultrasound (S‐HIFU) for locally recurrent prostate cancer after external beam…”
Get full text

High‐intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure by Blana, Andreas, Brown, Stephen C.W., Chaussy, Christian, Conti, Giario N., Eastham, James A., Ganzer, Roman, Murat, Francois J., Pasticier, Gilles, Rebillard, Xavier, Rewcastle, John C., Robertson, Cary N., Thuroff, Stefan, Ward, John F.

“…OBJECTIVES To compare the specificity and sensitivity of different definitions of biochemical failure in patients treated with high‐intensity focused…”
Get full text

Correlation of prostate‐specific antigen nadir and biochemical failure after high‐intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria – analysis from the @‐Registry by Ganzer, Roman, Robertson, Cary N., Ward, John F., Brown, Stephen C.W., Conti, Giario N., Murat, Francois J., Pasticier, Gilles, Rebillard, Xavier, Thuroff, Stefan, Wieland, Wolf F., Blana, Andreas

“…Study Type – Prognosis (retrospective cohort) Level of Evidence 2b What’s known on the subject? and What does the study add? The prostate‐specific antigen…”
Get full text

Impact of Gastrointestinal Side Effects on Patients' Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study by Noale, Marianna, Bruni, Alessio, Triggiani, Luca, Buglione, Michela, Bertoni, Filippo, Frassinelli, Luca, Montironi, Rodolfo, Corvò, Renzo, Zagonel, Vittorina, Porreca, Angelo, Bassi, Pierfrancesco, Gacci, Mauro, Conti, Giario Natale, Maggi, Stefania, Magrini, Stefano, The Pros-It Cnr Study Group

“…Radiotherapy (RT) represents an important therapeutic option for the treatment of localized prostate cancer. The aim of the current study is to examine…”
Get full text

Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study by Palumbo, Carlotta, Bruni, Alessio, Antonelli, Alessandro, Artibani, Walter, Bassi, Pierfrancesco, Bertoni, Filippo, Borghetti, Paolo, Bracarda, Sergio, Cicchetti, Alessandro, Corvò, Renzo, Gacci, Mauro, Ingrosso, Gianluca, Magrini, Stefano M, Maruzzo, Marco, Mirone, Vincenzo, Montironi, Rodolfo, Muto, Giovanni, Noale, Marianna, Porreca, Angelo, Russi, Elvio, Triggiani, Luca, Tubaro, Andrea, Valdagni, Riccardo, Maggi, Stefania, Conti, Giario N

“…This study analyzes patient health-related quality of life (QoL) 24-month after prostate cancer (PCa) diagnosis within the PROState cancer monitoring in ITaly…”
Get more information

The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study by Gacci, Mauro, Greco, Isabella, Artibani, Walter, Bassi, Pierfrancesco, Bertoni, Filippo, Bracarda, Sergio, Briganti, Alberto, Carmignani, Giorgio, Carmignani, Luca, Conti, Giario N, Corvò, Renzo, DE Nunzio, Cosimo, Fusco, Ferdinando, Graziotti, Pierpaolo, Maggi, Stefania, Magrini, Stefano M, Mirone, Vincenzo, Montironi, Rodolfo, Muto, Giovanni, Noale, Marianna, Pecoraro, Stefano, Porreca, Angelo, Ricardi, Umberto, Russi, Elvio, Salonia, Andrea, Simonato, Alchiede, Serni, Sergio, Tubaro, Andrea, Zagonel, Vittorina, Crepaldi, Gaetano

“…Prostate cancer (PCa) is the second most common neoplasm in male patients. To date, there's no certain indication about the maximum waiting time (WT)…”
Get more information

Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study by Porreca, Angelo, Noale, Marianna, Artibani, Walter, Bassi, Pier Francesco, Bertoni, Filippo, Bracarda, Sergio, Conti, Giario Natale, Corvò, Renzo, Gacci, Mauro, Graziotti, Pierpaolo, Magrini, Stefano Maria, Mirone, Vincenzo, Montironi, Rodolfo, Muto, Giovanni, Pecoraro, Stefano, Ricardi, Umberto, Russi, Elvio, Tubaro, Andrea, Zagonel, Vittorina, Crepaldi, Gaetano, Maggi, Stefania

“…The National Research Council (CNR) prostate cancer monitoring project in Italy (Pros-IT CNR) is an observational, prospective, ongoing, multicentre study…”
Get full text

Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder by Halachmi, Sarel, M.D, Moskovitz, Boaz, M.D, Maffezzini, Massimo, M.D, Conti, Giario, M.D, Verweij, Fabrizio, M.D, Kedar, Daniel, M.D, Sandri, Sandro D., M.D, Nativ, Ofer, M.D, Colombo, Renzo, M.D

“…Abstract Objectives Non-muscle invasive bladder cancer (NMIBC) classified as T1G3 represents one of the most challenging issues in urologic oncology. Although…”
Get full text

Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) by Buglione, Michela, Noale, Marianna, Bruni, Alessio, Antonelli, Alessandro, Bertoni, Filippo, Corvo', Renzo, Ricardi, Umberto, Borghetti, Paolo, Maddalo, Marta, Simeone, Claudio, Mazzeo, Ercole, Porreca, Angelo, Serni, Sergio, Bassi, Pierfrancesco, Gacci, Mauro, Mirone, Vincenzo, Montironi, Rodolfo, Tubaro, Andrea, Berruti, Alfredo, Conti, Giario Natale, Maggi, Stefania, Magrini, Stefano Maria, Triggiani, Luca

“…There are several treatments available to newly diagnosed prostate cancer (PCA) patients. Although surgery and radiotherapy (RT) with or without androgen…”
Get full text

U-CHANGE Project: a multidimensional consensus on how clinicians, patients and caregivers may approach together the new urothelial cancer scenario by Bracarda, Sergio, Iacovelli, Roberto, Baldazzi, Valentina, Zucali, Paolo Andrea, Gernone, Angela, Conti, Giario Natale, Pappagallo, Giovanni, Brunelli, Matteo, Bruzzi, Paolo, Fiorini, Edoardo, Magenta, Laura, Diomede, Francesco, Mereta, Federico, D'Aria, Irma, Magliano, Danilo, Liberatori, Monica, Cantù, Daniela, Croce, Davide, Eandi, Simone, Colombo, Giorgio Lorenzo, Ferrante, Fulvio, Salè, Emanuela Omodeo, Marinozzi, Andrea, Lenzi, Daniele, Remiddi, Francesca, Remiddi, Stefano

“…Advanced urothelial carcinoma remains aggressive and very hard to cure, while new treatments will pose a challenge for clinicians and healthcare funding…”
Get full text

Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document by Lapini, Alberto, Caffo, Orazio, Pappagallo, Giovanni, Iacovelli, Roberto, D'Angelillo, Rolando Maria, Vavassori, Vittorio, Ceccarelli, Roberta, Bracarda, Sergio, Jereczek-Fossa, Barbara Alicja, Da Pozzo, Luigi, Conti, Giario Natale

“…The availability of a number of agents that are efficacious in patients with metastatic prostate cancer (mPC) has led to them being used sequentially, and this…”
Get full text

Overview of the italian experience in surgical management of bladder cancer during first month of COVID-19 pandemic by Maccagnano, Carmen, Rocchini, Lorenzo, Montanari, Emanuele, Conti, Giario Natale, Petralia, Giovanni, Dehò, Federico, Bryan, Kadi-Ann, Contieri, Roberto, Hurle, Rodolfo

“…Overview of bladder cancer (BC) management in Italy during the first month of the COVID-19 pandemic (March 2020) with head to head comparison of the data from…”
Get full text

Bicalutamide Monotherapy Versus Flutamide Plus Goserelin in Prostate Cancer Patients: Results of an Italian Prostate Cancer Project Study by BOCCARDO, F, RUBAGOTTI, A, DITONNO, P, FERRARIS, V, LILLIU, S, MONTEFIORE, F, PORTOGHESE, F, SPANO, G, BARICHELLO, M, BATTAGLIA, M, CARMIGNANI, G, COMERI, G, CONTI, G, CRUCIANI, G, DAMMINO, S, DELLIPONTI, U

“…To compare the efficacy of bicalutamide monotherapy to maximal androgen blockade (MAB) in the treatment of advanced prostatic cancer. Previously untreated…”
Get full text

Cost‑effectiveness analysis of hexaminolevulinate (Hexvix®) guided cystoscopy in Non‑Muscle Invasive Bladder Cancer patients (NMIBC) in Italy by Craig Bennison, Stephanie Stephens, Giario Natale Conti

“…OBJECTIVE: To estimate the incremental cost‑effectiveness of hexaminolevulinate (Hexvix®) + Blue Light (H+BL) cystoscopy (compared to white light cystoscopy…”
Get full text

Invasion and metastasis: a historical perspective by Patriarca, Carlo, Pini, Giacomo Maria, Conti, Giario

“…The idea that neoplasms grow, becoming unresectable through dissemination, which is initially loco-regional, and systemic only in a later stage, is…”
Get full text

Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons by Evangelista, Laura, Bertoldo, Francesco, Boccardo, Francesco, Conti, Giario, Menchi, Ilario, Mungai, Francesco, Ricardi, Umberto, Bombardieri, Emilio

“…Different therapeutic options for the management of prostate cancer (PC) have been developed, and some are successful in providing crucial improvement in both…”
Get full text

Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project by Lapini, Alberto, Caffo, Orazio, Conti, Giario Natale, Pappagallo, Giovanni, Del Re, Marzia, D’Angelillo, Rolando Maria, Capoluongo, Ettore Domenico, Castiglione, Francesca, Brunelli, Matteo, Iacovelli, Roberto, De Giorgi, Ugo, Bracarda, Sergio

“…The recent approval of PARP inhibitors for the treatment of metastatic –castration-resistant prostate cancer (mCRPC) patients with BRCA mutations firstly…”
Get full text

Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel by Baldari, Sergio, Boni, Giuseppe, Bortolus, Roberto, Caffo, Orazio, Conti, Giario, De Vincentis, Giuseppe, Monari, Fabio, Procopio, Giuseppe, Santini, Daniele, Seregni, Ettore, Valdagni, Riccardo

“…Radium-223, a calcium mimetic bone-seeking radionuclide that selectively targets bone metastases with alpha particles, is approved for the treatment of men…”
Get full text

Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of care by De Vincentis, Giuseppe, Monari, Fabio, Baldari, Sergio, Salgarello, Matteo, Frantellizzi, Viviana, Salvi, Elisabetta, Reale, Luigi, Napolitano, Silvia, Conti, Giario, Cortesi, Enrico

“…To describe the journey of patients with metastatic castration-resistant prostate cancer (mCRPC) in treatment with radium-223. A multiperspective analysis was…”
Get full text